what are people's serious thoughts on EU approval and impact on price per share? Is the EU approval baked into the price already? I would think not really - with BIO Tech stocks they way they are it seems you can't trust them until it happens with a few exceptions....Can the EU approval and the sales in EU place DNDN into profitability? Thanks.
EU already baked in, people have been talking about it forever and have you ever heard the phrase buy the rumor sell the newz? I also don't think it matters who approves what, and where. As long as it is costing them $.74 to sell every $1.00, nothing will change.
Provenge might be a great drug, and one I would look at if I ever needed that kind of treatment, but that does not translate into high stock prices. the only hope longs have is a buyout.